H K S C Hong Kong Stem Cell

The awarding of this year’s Nobel Prize in medicine to John Gurdon and Shinya Yamanaka for their pioneer adult stem-cell research has been held as both beautiful and ethical. This prestigious award should encourage institutions to switch funding from embryonic stem-cell research to adult stem-cell research which is more effective and without moral controversy.

The awarding of the Nobel Prize in physiology or medicine to these two pioneers represents an important milestone in recognizing the superior potential of adult stem-cell research over the unethical, destructive experimentation on human embryonic stem-cells.

In the past years, the attempts to clone human embryos and the bizarre experiments to create mixed human/non-human embryos have delivered nothing. In contrast, the transformation of adult stem-cells is making great progress. This is indeed science at its best: both beautiful and ethical.

Both of these scientists were involved in research into changing mature cells into stem-cells which can be harvested in the potential treatment for a variety of diseases. This wonderful discovery stresses the key role that nonembryonic stem-cells play in the development of new medical therapies.

The work of these two outstanding pioneer scientists should encourage government and institutions to switch funding from embryonic stem-cell research to adult stem-cell research.

Since science serves human ends, not its own, scientific research must always respect the moral law. The dedicated research by these two scientists offers significant progress using adult stem-cells which is a sound moral alternative and offers better clinical results.

Reference:
http://www.reporternews.com/news/2012/nov/16/letter-adult-stem-cell-research-is-future-of/